Yayın: Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer-s Disease: Oral or Patch?
item.page.program
Kurum Yazarları
Yazarlar
Danışman
Tarih
2014-12-01T00:00:00Z
item.page.language
item.page.type
Article
Yayımcı
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
Objective: Rivastigmine is commonly used for the treatment of Alzheimer-s disease (AD). All cholinesterase inhibitors, including rivastigmine, may cause cardiac side effects. The aim of this study is to compare the electrocardiographic (ECG) and hypotensive effects of formulations of rivastigmine.
Açıklama
item.page.source
item.page.keywords
Konusu
Alıntı
Isik A. T. , Soysal P., YAY A., -Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer-s Disease: Oral or Patch?-, AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, cilt.29, ss.735-738, 2014